Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Degenerative Diseases, Central Nervous System
0.300 Biomarker group CTD_human Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy. 15964507 2005
CUI: C0524851
Disease: Neurodegenerative Disorders
Neurodegenerative Disorders
0.300 Biomarker group CTD_human Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy. 15964507 2005
CUI: C0751733
Disease: Degenerative Diseases, Spinal Cord
Degenerative Diseases, Spinal Cord
0.300 Biomarker group CTD_human Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy. 15964507 2005
Adverse effects, not elsewhere classified
0.100 GeneticVariation disease GWASCAT Genetic variation in the Estonian population: pharmacogenomics study of adverse drug effects using electronic health records. 30420678 2019
CUI: C0202177
Disease: Phospholipid measurement
Phospholipid measurement
0.100 GeneticVariation phenotype GWASDB Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. 21829377 2011
CUI: C0024117
Disease: Chronic Obstructive Airway Disease
Chronic Obstructive Airway Disease
0.010 Biomarker disease BEFREE Chronic CS exposure was significantly linked with alterations in pathways encoding for energy, phagocytosis, and DNA repair and triggered differential expression of genes or exons previously unreported to associate with CS or COPD, including Lox, involved in matrix remodeling, Gp2, linked to goblet cells, and Slc22a12 and Agpat3, involved in purine and glycerolipid metabolism, respectively. 28575117 2017